Kamada Ltd (KMDA)
5.75
+0.30
(+5.50%)
USD |
NASDAQ |
May 03, 16:00
5.75
0.00 (0.00%)
After-Hours: 20:00
Kamada Revenue (Quarterly): 36.43M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.43M |
| September 30, 2023 | 37.93M |
| June 30, 2023 | 37.44M |
| March 31, 2023 | 30.71M |
| December 31, 2022 | 45.44M |
| September 30, 2022 | 32.22M |
| June 30, 2022 | 23.59M |
| March 31, 2022 | 28.09M |
| December 31, 2021 | 31.47M |
| September 30, 2021 | 23.03M |
| June 30, 2021 | 24.24M |
| March 31, 2021 | 24.90M |
| December 31, 2020 | 31.54M |
| September 30, 2020 | 35.32M |
| June 30, 2020 | 33.09M |
| March 31, 2020 | 33.29M |
| December 31, 2019 | 32.07M |
| September 30, 2019 | 33.07M |
| June 30, 2019 | 35.25M |
| March 31, 2019 | 26.80M |
| December 31, 2018 | 48.21M |
| September 30, 2018 | 14.98M |
| June 30, 2018 | 33.84M |
| March 31, 2018 | 17.44M |
| Date | Value |
|---|---|
| December 31, 2017 | 35.71M |
| September 30, 2017 | 22.92M |
| June 30, 2017 | 32.55M |
| March 31, 2017 | 11.65M |
| December 31, 2016 | 24.26M |
| September 30, 2016 | 19.37M |
| June 30, 2016 | 19.07M |
| March 31, 2016 | 14.80M |
| December 31, 2015 | 25.66M |
| September 30, 2015 | 16.07M |
| June 30, 2015 | 19.25M |
| March 31, 2015 | 8.93M |
| December 31, 2014 | 24.93M |
| September 30, 2014 | 17.15M |
| June 30, 2014 | 15.80M |
| March 31, 2014 | 13.19M |
| December 31, 2013 | 24.43M |
| September 30, 2013 | 17.48M |
| June 30, 2013 | 16.12M |
| March 31, 2013 | 12.60M |
| December 31, 2012 | 21.64M |
| September 30, 2012 | 17.68M |
| June 30, 2012 | 13.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
23.03M
Minimum
Sep 2021
45.44M
Maximum
Dec 2022
32.06M
Average
32.22M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Compugen Ltd | 33.46M |
| Pluri Inc | 0.105M |
| BioLine Rx Ltd | 4.80M |
| Can Fite Biofarma Ltd | 0.155M |
| BiomX Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.058M |
| Total Expenses (Quarterly) | 33.66M |
| EPS Diluted (Quarterly) | 0.09 |
| Enterprise Value | 257.62M |
| Gross Profit Margin (Quarterly) | 39.56% |
| Profit Margin (Quarterly) | 13.88% |
| Earnings Yield | 2.61% |
| Operating Earnings Yield | 3.48% |
| Normalized Earnings Yield | 2.538 |